3. Other investments
UNIQA has applied the deferral approach for IFRS 9 since 1 January 2018. This enables UNIQA to postpone the date of first-time application of IFRS 9 until IFRS 17 comes into force.
Classification
UNIQA classifies non-derivative financial assets to the following categories: financial assets at fair value through profit or loss, loans and receivables, and financial assets available for sale.
Non-derivative financial liabilities are classified as measured at amortised cost.
Derivatives are recognised as financial assets or liabilities at fair value through profit or loss.
Recognition and derecognition
Loans, receivables and issued debt securities are recognised from the date on which they arise. All other financial assets and liabilities are recognised for the first time on the settlement date. Financial assets are derecognised when the contractual rights to cash flows from an asset expire or the rights to receive the cash flows in a transaction in which all major risks and opportunities connected with the ownership of the financial asset are transferred.
In securities lending transactions, the risks and rewards associated with the securities lent, such as the price risk, the credit risk and the income from dividends and other income from the securities lent, remain with the lender. As a result, the securities lent are not derecognised. The assets transferred are available-for-sale financial assets. Cash collateral in connection with securities lending transactions is reported under the item “Cash and cash equivalents”.
Financial liabilities are derecognised when the contractual obligation is fulfilled, extinguished or expired.
Derivatives are also recognised from the date on which they arise.
Measurement
With the exception of loans, investments are listed at their fair value. The loans are accounted for at amortised cost.
Financial assets at fair value through profit or loss
Financial assets are recognised at fair value through profit or loss if the asset is either held for trading or is designated at fair value and recognised in profit and loss (fair value option). These include ABS bonds, structured bonds, hedge funds and investment certificates whose original classification fell within this category.
The fair value option is applied to structured products that are not split between the underlying transaction and the derivative but are accounted for as a unit. Unrealised gains and losses are recognised in profit/(loss) for the period.
Derivatives are used within the limits permitted under the Austrian Insurance Supervisory Act for hedging investments and for increasing earnings. All fluctuations in value are recognised in profit/(loss) for the period. Financial assets from derivative financial instruments are recognised under other investments. Financial liabilities from derivative financial instruments are recognised under financial liabilities.
Available-for-sale financial assets
Available-for-sale financial assets are initially measured at fair value plus directly attributable transaction costs. Subsequently, available-for-sale financial assets are measured at fair value. Corresponding value changes are, with the exception of impairment and foreign exchange differences in the case of available-for-sale debt securities, recognised in the accumulated profits in equity. When an asset is derecognised, the accumulated other comprehensive income is reclassified to profit/(loss) for the period.
Loans and receivables
When first recognised, such assets are measured at their fair value plus directly attributable transaction costs. Subsequently, they are measured at amortised cost using the effective interest method.
Non-derivative financial liabilities
When first recognised, non-derivative financial liabilities are measured at fair value less directly attributable transaction costs. Subsequently, these financial liabilities are measured at amortised cost using the effective interest method.
Investments are broken down into the following classes and categories of financial instruments:
In € thousand |
Variable-income securities |
Fixed-income securities |
Loans and |
Derivative financial instruments |
Investments under investment contracts |
Total |
Financial assets at fair value through profit or loss |
24,538 |
308,029 |
0 |
20,804 |
56,395 |
409,767 |
Available-for-sale financial assets |
840,857 |
15,702,491 |
0 |
0 |
0 |
16,543,348 |
Loans and receivables |
0 |
172,985 |
507,715 |
0 |
0 |
680,701 |
Total |
865,396 |
16,183,505 |
507,715 |
20,804 |
56,395 |
17,633,815 |
of which fair value option |
24,538 |
308,029 |
0 |
0 |
0 |
332,567 |
In € thousand |
Variable- |
Fixed- |
Loans and |
Derivative financial instruments |
Investments under investment contracts |
Total |
Financial assets at fair value through profit or loss |
29,415 |
315,968 |
0 |
165,037 |
60,419 |
570,840 |
Available-for-sale financial assets |
856,090 |
16,149,214 |
0 |
0 |
0 |
17,005,304 |
Loans and receivables |
0 |
216,459 |
471,723 |
0 |
0 |
688,182 |
Total |
885,505 |
16,681,642 |
471,723 |
165,037 |
60,419 |
18,264,326 |
of which fair value option |
29,415 |
315,968 |
0 |
0 |
0 |
345,384 |
Impairments
Non-derivative financial assets
Financial assets not designated at fair value through profit or loss are tested on every reporting date to determine whether there is any objective indication of impairment. For debt instruments and assets in the category “Loans and receivables”, this test is executed within the framework of an internal impairment process. If objective indicators suggest that the value currently attributed is not tenable, an impairment is recognised.
Objective indications that financial assets are impaired are:
- the default or delay of a debtor,
- the opening of bankruptcy proceedings for a debtor, or signs indicating that such proceedings are imminent,
- adverse changes in the rating of borrowers or issuers,
- changes in the market activity of a security, or
- other observable data that indicate a significant decrease in the expected payments from a group of financial assets.
In the case of an investment in an equity instrument, a significant or prolonged decline in the fair value below its cost is also objective evidence of impairment. A significant decrease is a decrease of 20 per cent, and a prolonged decline is one that lasts for at least nine months.
Financial assets measured at amortised cost
Impairment is calculated as the difference between the carrying amount and the present value of the estimated future cash flows, discounted at the original effective interest rate of the asset. Losses are recognised in profit/ (loss) for the period. If there are no realistic chances of recovering the asset, an impairment has to be recognised. In case of an event that causes a reversal of impairment losses, this is recognised in profit/(loss) for the period. In the event of a definitive non-performance, the asset is derecognised.
Available-for-sale financial assets
Impairment of available-for-sale financial assets is recognised in profit/(loss) for the period by reclassifying the losses accumulated in equity. The accumulated loss that is reclassified from equity to profit/(loss) for the period is the difference between the acquisition cost, net of any redemptions and amortisations and current fair value, less any impairment loss previously recognised in profit or loss. If the fair value of an impaired, available-for-sale debt instrument increases in a subsequent period and the increase can be objectively related to an event occurring after the impairment was recognised, the impairment is reversed, with the amount of the reversal recognised in profit or loss. Reversals of impairment losses of equity instruments held at fair value cannot be recognised in profit/(loss) for the period.
Determination of fair value
A range of accounting policies and disclosures requires the determination of the fair value of financial and non- financial assets and liabilities. UNIQA has defined a control framework with regard to the determination of fair value. This includes a measurement team, which bears general responsibility for monitoring all major measurements of fair value, including Level 3 fair values, and reports directly to the respective Member of the Management Board.
A regular review is carried out of the major unobservable inputs and the measurement adjustments. If information from third parties (e.g. price quotations from brokers or price information services) is used to determine fair values, the evidence obtained from third parties is examined in order to see whether such measurements meet the requirements of IFRSs. The level in the fair value hierarchy to which these measurements are attributable is also tested. Major items in the measurement are reported to the Audit Committee.
As far as possible, UNIQA uses data that are observable on the market when determining the fair value of an asset or a liability. Based on the inputs used in the valuation techniques, the fair values are assigned to different levels in the fair value hierarchy.
- Level 1: quoted prices (unadjusted) in active markets for identical assets and liabilities. At UNIQA, these primarily involve quoted shares, quoted bonds and quoted investment funds.
- Level 2: valuation parameters that are not quoted prices included in Level 1 but which can be observed for the asset or liability either directly (i.e. as a price) or indirectly (i.e. derived from prices), or are based on prices on markets that have been classified as inactive. The parameters that can be observed here include, for example, exchange rates, yield curves and volatilities. At UNIQA, these include in particular quoted bonds that do not fulfil the conditions under Level 1, along with structured products.
- Level 3: valuation parameters for assets or liabilities that are not based or are only partly based on observable market data. The valuations here primarily involve application of the discounted cash flow method, comparative procedures with instruments for which there are observable prices and other procedures. As there are no observable parameters here in many cases, the estimates used can have a significant impact on the result of the valuation. At UNIQA, it is primarily other equity investments, private equity and hedge funds, ABS and structured products that do not fulfil the conditions under Level 2 that are assigned to Level 3.
If the inputs used to determine the fair value of an asset or a liability can be assigned to different levels of the fair value hierarchy, the entire fair value measurement is assigned to the respective level of the fair value hierarchy that corresponds to the lowest input significant for the measurement overall.
UNIQA recognises reclassifications between different levels of the fair value hierarchy at the end of the reporting period in which the change occurred.
The valuation processes and methods are as follows:
Financial instruments measured at fair value
For the valuation of capital investments, techniques best suited for the establishment of corresponding value are applied. The following standard valuation techniques are applied for financial instruments which come under levels 2 and 3:
- Market approach
The valuation method in the market approach is based on prices or other applicable information from market transactions which involve identical or comparable assets and liabilities. - Income approach
The income approach corresponds to the method whereby the future (expected) payment flows or earnings are inferred on a current amount. - Cost approach
The cost approach generally corresponds to the value which would have to be applied in order to procure the asset once again.
Non-financial assets and loans
The fair value of investment property is determined within the scope of the impairment test.
The loans are accounted for at amortised cost. Any required impairment is determined with due regard to the collateral and the debtor’s creditworthiness.
Financial liabilities
The fair value of financial liabilities and subordinated liabilities is determined using the discounted cash flow method. Yield curves and CDS spreads are used as inputs.
Valuation techniques and inputs in the determination of fair values
Assets |
Price method |
Input factors |
Price model |
Fixed-income securities |
|
|
|
Listed bonds |
Listed price |
– |
– |
Unlisted bonds |
Theoretical price |
CDS spread, yield curves |
Present value method |
Unquoted asset backed securities |
Theoretical price |
– |
Discounted cash flow, single deal review, peer |
Infrastructure financing |
Theoretical price |
– |
Discounted cash flow |
Variable-income securities |
|
|
|
Listed shares/investment funds |
Listed price |
– |
– |
Private equities |
Theoretical price |
Certified net asset values |
Net asset value method |
Hedge funds |
Theoretical price |
Certified net asset values |
Net asset value method |
Other shares |
Theoretical value |
WACC, (long-term) revenue growth rate, (long-term) profit margins, control premium |
Expert opinion |
Derivative financial instruments |
|
|
|
Equity basket certificate |
Theoretical price |
CDS spread, yield curves, volatilities (FX, cap/floor, swaption, constant maturity swap, shares) |
Black-Scholes Monte Carlo N-DIM |
CMS floating rate note |
Theoretical price |
CDS spread, yield curves, volatilities (FX, cap/floor, swaption, constant maturity swap, shares) |
LIBOR market model, Hull-White-Garman-Kohlhagen Monte Carlo |
CMS spread certificate |
Theoretical price |
CDS spread, yield curves, volatilities (FX, cap/floor, swaption, constant maturity swap, shares) |
Contract specific model |
FX (Binary) option |
Theoretical price |
CDS spread, yield curves, volatilities (FX, cap/floor, swaption, constant maturity swap, shares) |
Black-Scholes-Garman-Kohlhagen Monte Carlo N-DIM |
Option (Inflation, OTC, OTC FX options) |
Theoretical price |
CDS spread, yield curves, volatilities (FX, cap/floor, swaption, constant maturity swap, shares) |
Black-Scholes Monte Carlo N-DIM, contract specific model, inflation market model NKIS |
Structured bonds |
Theoretical price |
CDS spread, yield curves, volatilities (FX, cap/floor, swaption, constant maturity swap, shares) |
Black-Scholes-Garman-Kohlhagen Monte Carlo N-DIM, LMM |
Swap, cross currency swap |
Theoretical price |
CDS spread, yield curves, volatilities (FX, cap/floor, swaption, constant maturity swap, shares) |
Black-Scholes-Garman-Kohlhagen Monte Carlo N-DIM, Black–76-model, LIBOR market model, contract specific model |
Swaption, total return swaption |
Theoretical price |
CDS spread, yield curves, volatilities (FX, cap/floor, swaption, constant maturity swap, shares) |
Black - basis point volatility, contract specific model |
Investments under investment contracts |
|
|
|
Listed shares/investment funds |
Listed price |
– |
– |
Unlisted investment funds |
Theoretical price |
CDS spread, yield curves |
Present value method |
Valuation hierarchy
Assets and liabilities measured at fair value
In € thousand |
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
31/12/2018 |
31/12/2017 |
31/12/2018 |
31/12/2017 |
31/12/2018 |
31/12/2017 |
31/12/2018 |
31/12/2017 |
|
Available-for-sale financial assets |
|
|
|
|
|
|
|
|
Variable-income securities |
695,196 |
727,791 |
1,135 |
125 |
144,526 |
128,173 |
840,857 |
856,090 |
Fixed-income securities |
12,567,999 |
13,287,001 |
2,633,039 |
2,553,636 |
501,453 |
308,578 |
15,702,491 |
16,149,214 |
Total |
13,263,195 |
14,014,792 |
2,634,175 |
2,553,761 |
645,979 |
436,751 |
16,543,348 |
17,005,304 |
Financial assets at fair value through profit or loss |
|
|
|
|
|
|
|
|
Variable-income securities |
0 |
0 |
14,445 |
17,684 |
10,094 |
11,732 |
24,538 |
29,415 |
Fixed-income securities |
197,100 |
175,635 |
48,235 |
78,774 |
62,694 |
61,560 |
308,029 |
315,968 |
Derivative financial instruments |
12 |
20 |
5,205 |
84,249 |
15,587 |
80,767 |
20,804 |
165,037 |
Investments under investment contracts |
49,008 |
56,630 |
932 |
971 |
6,456 |
2,818 |
56,395 |
60,419 |
Total |
246,120 |
232,285 |
68,816 |
181,678 |
94,830 |
156,876 |
409,767 |
570,840 |
In € thousand |
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
31/12/2018 |
31/12/2017 |
31/12/2018 |
31/12/2017 |
31/12/2018 |
31/12/2017 |
31/12/2018 |
31/12/2017 |
|
Financial liabilities |
|
|
|
|
|
|
|
|
Derivative financial instruments |
0 |
0 |
13,345 |
24,208 |
0 |
2,307 |
13,345 |
26,514 |
Total |
0 |
0 |
13,345 |
24,208 |
0 |
2,307 |
13,345 |
26,514 |
Fair values of assets and liabilities measured at amortised cost
In € thousand |
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
31/12/2018 |
31/12/2017 |
31/12/2018 |
31/12/2017 |
31/12/2018 |
31/12/2017 |
31/12/2018 |
31/12/2017 |
|
Investment property |
0 |
0 |
0 |
0 |
2,086,093 |
2,217,627 |
2,086,093 |
2,217,627 |
Loans and receivables |
|
|
|
|
|
|
|
|
Loans and other investments |
0 |
0 |
395,016 |
328,323 |
112,700 |
143,400 |
507,715 |
471,723 |
Fixed-income securities |
30,789 |
51,579 |
123,862 |
155,378 |
31,443 |
32,768 |
186,094 |
239,724 |
Total |
30,789 |
51,579 |
518,878 |
483,701 |
144,143 |
176,168 |
693,809 |
711,447 |
In € thousand |
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
31/12/2018 |
31/12/2017 |
31/12/2018 |
31/12/2017 |
31/12/2018 |
31/12/2017 |
31/12/2018 |
31/12/2017 |
|
Financial liabilities |
|
|
|
|
|
|
|
|
Liabilities from collateral received for securities lending |
0 |
0 |
0 |
0 |
772,196 |
0 |
772,196 |
0 |
Liabilities from loans |
0 |
0 |
0 |
0 |
12,943 |
13,837 |
12,943 |
13,837 |
Total |
0 |
0 |
0 |
0 |
785,139 |
13,837 |
785,139 |
13,837 |
Subordinated liabilities |
959,400 |
1,088,161 |
0 |
0 |
0 |
0 |
959,400 |
1,088,161 |
Transfers between levels 1 and 2
In the reporting period transfers from Level 1 to Level 2 were made in the amount of €443,997 thousand (2017: €202,399 thousand) and from Level 2 to Level 1 in the amount of €234,586 thousand (2017: €1,508,494 thousand). These are attributable primarily to changes in trading frequency and trading activity.
Level 3 financial instruments
The following table shows the changes to the fair values of financial instruments whose valuation techniques are not based on observable inputs.
In € thousand |
RZB shares |
Fixed-income securities |
Other |
Total |
||||
|
2018 |
2017 |
2018 |
2017 |
2018 |
2017 |
2018 |
2017 |
At 1 January |
0 |
126,071 |
308,578 |
427,840 |
282,743 |
286,039 |
591,321 |
839,950 |
Transfers from Level 3 to Level 1 |
0 |
–126,071 |
–24 |
0 |
–6 |
0 |
–29 |
–126,071 |
Transfers to Level 3 |
0 |
0 |
772 |
107,276 |
0 |
1,741 |
772 |
109,017 |
Gains and losses recognised in profit or loss |
0 |
0 |
1,630 |
–24,697 |
–12,527 |
9,579 |
–10,897 |
–15,119 |
Gains and losses recognised in other comprehensive income |
0 |
0 |
–14,445 |
–1,573 |
3,290 |
2,178 |
–11,155 |
605 |
Additions |
0 |
0 |
217,244 |
101,253 |
43,676 |
11,929 |
260,920 |
113,182 |
Disposals |
0 |
0 |
–12,273 |
–301,521 |
–77,814 |
–24,514 |
–90,087 |
–326,035 |
Changes from currency translation |
0 |
0 |
–29 |
0 |
–6 |
–7 |
–35 |
–7 |
Change in basis of consolidation |
0 |
0 |
0 |
0 |
0 |
–4,202 |
0 |
–4,202 |
At 31 December |
0 |
0 |
501,453 |
308,578 |
239,356 |
282,743 |
740,809 |
591,321 |
Sensitivities
For the most important financial instruments in Level 3, an increase in the discount rate by 100 basis points results in a 5.7 per cent reduction in the value (2017: 3.7 per cent). A reduction in the discount rate by 100 basis points results in a 6.4 per cent increase in value (2017: 3.7 per cent).
|
Fair value |
|
In € thousand |
31/12/2018 |
31/12/2017 |
Transferred financial assets from securities lending |
772,406 |
0 |
Liabilities from collateral received for securities lending |
772,196 |
0 |
Net position |
210 |
0 |
The carrying amounts of the transferred financial assets of the securities lending transactions and the liabilities from collateral received for securities lending transactions correspond to the fair values.
In € thousand |
31/12/2018 |
31/12/2017 |
Loans |
|
|
Loans to affiliated unconsolidated companies |
4,382 |
0 |
Mortgage loans |
14,100 |
17,151 |
Loans and advance payments on policies |
13,481 |
8,409 |
Other loans |
54,986 |
7,589 |
Total |
86,950 |
33,148 |
Other investments |
|
|
Bank deposits |
395,016 |
328,323 |
Deposits retained on assumed reinsurance |
25,750 |
110,252 |
Total |
420,766 |
438,575 |
Total sum |
507,715 |
471,723 |
The carrying amounts of the loans and other investments correspond to their fair values. The measurement is based on collateral and the creditworthiness of the debtor; for deposits with banks it is based on quoted prices.
In € thousand |
31/12/2018 |
31/12/2017 |
At 1 January |
–6,339 |
–25,832 |
Allocation |
–114 |
–1,025 |
Use |
1,870 |
19,056 |
Reversal |
933 |
1,502 |
Currency translation |
–7 |
–39 |
At 31 December |
–3,657 |
–6,339 |
In € thousand |
31/12/2018 |
31/12/2017 |
Up to 1 year |
4,227 |
2,639 |
More than 1 year and up to 5 years |
16,703 |
8,575 |
More than 5 years up to 10 years |
56,240 |
12,377 |
More than 10 years |
9,780 |
9,558 |
Total |
86,950 |
33,148 |